financetom
Business
financetom
/
Business
/
Meta wins appeal of court order to stop using its name in Brazil
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta wins appeal of court order to stop using its name in Brazil
Mar 15, 2024 7:08 PM

SAO PAULO, March 15 (Reuters) - Facebook-parent Meta

on Friday won an appeal overturning a previous court

ruling that barred it from using its name in Brazil due to

confusion with another company.

Mark Zuckerberg's tech company was in late February ordered

to stop using its name in Brazil within 30 days after a

Brazilian computer services provider won a favourable ruling

arguing it already owned rights to the name and had as a result

of the U.S. branding been wrongly cited in over 100 lawsuits.

In a statement, the Brazilian Meta said it owned the

name's rights in Brazil, adding it believed the law should be

followed "regardless of business decisions made by groups that

want to operate in our country".

The company can still appeal the decision.

U.S. Meta, formerly called Facebook, changed its name in

2021 in a rebrand that focused on building the "metaverse," a

shared virtual environment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wells Fargo CEO expresses more confidence in regulatory fixes
Wells Fargo CEO expresses more confidence in regulatory fixes
Dec 11, 2024
NEW YORK (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely detailed plans...
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
Dec 11, 2024
On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...
Wells Fargo CEO expresses more confidence in regulatory fixes
Wells Fargo CEO expresses more confidence in regulatory fixes
Dec 11, 2024
NEW YORK, Dec 11 (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely...
Marchex Joining Microsoft's Cloud AI Partner Program
Marchex Joining Microsoft's Cloud AI Partner Program
Dec 11, 2024
09:33 AM EST, 12/11/2024 (MT Newswires) -- Marchex ( MCHX ) said Wednesday it has signed an agreement to join Microsoft's ( MSFT ) Cloud AI Partner Program. The move will give Marchex ( MCHX ) the ability to transact via Microsoft's ( MSFT ) Azure Marketplace, which will connect clients to its products, the company said. The products will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved